BioInformant

Your Global Leader in Stem Cell Market Research

Home » market intelligence » Page 3

Cord Blood Banks – Anticipate and Serve the Needs of Your Clients, Or Your Competitors Will

By

One of BioInformant’s market reports is the “Complete 2015-16 Cord Blood Banking Industry Report.” Popular among cord blood banks, biobanks, cell therapy companies, and industry investors, the report is filled with 204 pages of critical industry metrics.

Recently, a business partner asked me what makes this market report unique.

It is an excellent question, because there are massive differences between this report and other variations of market and industry reports for the cord blood industry.

To learn more about the importance of choosing a qualified provider of cord blood market information, read the article, “Why I Respectfully Disagree with Other Market Intelligence Reports about Cord Blood Banking.” [Read more…]

Subscribe to BioInformant’s Network Before It Becomes Premium Content

By

As the first and only market research firm dedicated to tracking stem cell markets, BioInformant is your leading source of industry news. In 2015, we released 250 articles about breaking stem cell and cord blood news. In 2016, we will be releasing 500 original content articles about critical stem cell industry news, highlighting how they will impact you, your company, and your strategies for competing within the marketplace.

As the world’s leading market research firm for the stem cell industry, we also use dashboards of key industry metrics to alert you to changing dynamics, before your competition.

However, soon BioInformant will be changing to a premium content network. [Read more…]

Top Five Mesenchymal Stem Cell (MSC) Influencers on Twitter

By

This post identifies the top five mesenchymal stem cell (MSC) influencers on Twitter. This assessment was conducted using the social analytics platform Topsy.com and the hashtag “#mesenchymal”.

As you can see from the figure below, the first place Twitter account is “MesenchymalCellNews” (@mesenchymal_cell), which self-describes itself as the “online resource for the mesenchymal cell community.”  Interestingly, the second place Twitter account is “Cord Blood News” (@cord_blood_news). This account holder appears to be posting about topics pertaining to both cord blood and cord tissue, as MSCs are prevalent in large quantities in cord tissue, also called Wharton’s Jelly. Of course, I am pleased to have our account, “BioInformant” (@StemCellMarket), appear third on this list, because our Twitter feed is dedicated to posts about stem cell industry trends. [Read more…]

Wishing All of BioInformant’s Stem Cell Clients and Partners a Prosperous 2016!

By

As we are now just hours from 2016, I wanted to take a moment to wish all of BioInformant’s stem cell clients and partners a prosperous New Year! 2015 was an incredible year for us, in that we introduced hundreds of new clients to our products and services, sponsored and attended a wide range of stem cell industry conferences, expanded our portfolio of products, and reached new levels of visibility in the marketplace.

However, the single important metric to us is that we fueled massive new levels of success for our clients. On average, our clients that claimed stem cell or cord blood market intelligence increased revenue 3X faster than had done in prior years. There are many reasons why market intelligence works to increase revenue. It eliminates unnecessary expenses by identifying market segments that are shrinking (or experiencing slow growth), and at that same time, it drives new revenue by identifying promising new markets to target.

However, in my experience, the single biggest power of market intelligence is that it positions you to make smarter decisions, faster.  [Read more…]

Cord Tissue Storage Impacted by the Global Mesenchymal Stem Cell (MSC) Market

By

For our clients in the cord blood banking sector, we highly recommend that you review the report, “Mesenchymal Stem Cells – Advances & Applications.” This MSC report will uniquely inform you about opportunities related to cord tissue storage and future applications with cord tissue derived MSCs.

Remember, to benefit from the global MSC market, you need to anticipate and serve the needs of your clients – or other cord blood banks will.

Key questions answered in the report are:
(Regenerative Medicine = RM; Cell Therapy= CT)

[Read more…]

BioInformant's World-Class Clients